Elbasvir

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 319 publications

Elbasvir Inhibits Hepatitis E Virus Internalization and, in Combination with Ribavirin, Achieves Sustained Viral Suppression In Vitro.

Elbasvir Inhibits Hepatitis E Virus Internalization and, in Combination with Ribavirin, Achieves Sustained Viral Suppression In Vitro.

Journal: Pathogens (Basel, Switzerland)
Published: April 25, 2026

Deep learning-based prediction of drug-target interactions between antiviral drugs and SARS-CoV-2 proteins using an image-based representation approach.

Deep learning-based prediction of drug-target interactions between antiviral drugs and SARS-CoV-2 proteins using an image-based representation approach.

Journal: Computational biology and chemistry
Published: April 21, 2026

Antiviral treatment for chronic viral hepatitis B and C in children in Ostrava

Antiviral treatment for chronic viral hepatitis B and C in children in Ostrava

Journal: Klinicka mikrobiologie a infekcni lekarstvi
Published: February 24, 2026

hnRNPC facilitates coronavirus replication by directly binding the frameshift-stimulatory element of viral genomic RNA.

hnRNPC facilitates coronavirus replication by directly binding the frameshift-stimulatory element of viral genomic RNA.

Journal: PLoS pathogens
Published: January 23, 2026

Repurposing antiviral drugs targeting RNA viruses: A focus on the fusion protein of human metapneumovirus.

Repurposing antiviral drugs targeting RNA viruses: A focus on the fusion protein of human metapneumovirus.

Journal: Northern clinics of Istanbul
Published: November 27, 2025

LDHC4 promotes ovarian cancer progression through H4K12 lactylation to regulate PGK1 expression and modulate glycolysis.

LDHC4 promotes ovarian cancer progression through H4K12 lactylation to regulate PGK1 expression and modulate glycolysis.

Journal: Journal of translational medicine
Published: September 08, 2025

Rational design and relative bioperformance of high drug load grazoprevir amorphous nanoparticle formulations.

Rational design and relative bioperformance of high drug load grazoprevir amorphous nanoparticle formulations.

Journal: Pharmaceutical development and technology
Published: August 07, 2025

Elbasvir triggers ferroptosis in esophageal squamous cell carcinoma through NCOA4-mediated ferritinophagy.

Elbasvir triggers ferroptosis in esophageal squamous cell carcinoma through NCOA4-mediated ferritinophagy.

Journal: Medical oncology (Northwood, London, England)
Published: July 31, 2025

Conformational Trajectory of the Molecular Chameleon Grazoprevir From Formulation to Target-Bound.

Conformational Trajectory of the Molecular Chameleon Grazoprevir From Formulation to Target-Bound.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: July 16, 2025

High-throughput automated molecular replacement for small-molecule MicroED data.

High-throughput automated molecular replacement for small-molecule MicroED data.

Journal: IUCrJ
Published: July 11, 2025

Molecular chameleons adaptability in target binding.

Molecular chameleons adaptability in target binding.

Journal: Structural dynamics (Melville, N.Y.)
Published: April 04, 2025

Targeting Telomere Shelterin Protein TPP1 with Elbasvir: Induction of Autophagy and Suppression of Esophageal Cancer Tumorigenesis.

Targeting Telomere Shelterin Protein TPP1 with Elbasvir: Induction of Autophagy and Suppression of Esophageal Cancer Tumorigenesis.

Journal: Anti-cancer agents in medicinal chemistry
Published: March 16, 2025
Showing 1-12 of 319

Last Updated: 09/26/2026